Sulfonamides

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 07.10.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Bacteriostatically active chemotherapeutic agents, e.g. DADPS, sulfadiazine or cotrimoxazole.

Pharmacodynamics (Effect)This section has been translated automatically.

Antimetabolites (competitive inhibitors) of p-aminobenzoic acid (PABA), the key enzyme in folic acid synthesis.

Limited indicationThis section has been translated automatically.

Desiccosis, newborns, thyroid dysfunction.

Undesirable effectsThis section has been translated automatically.

Flu-like symptoms, pneumonia, BB changes, oligospermia, gastrointestinal disorders, jaundice, hepatitis, oliguria, nephrotic syndrome, allergic reactions, purpura, photosensitization, drug-induced LE, induction of panarteritis nodosa, DDS syndrome, cross-allergy with sulfonylureas, thiazides and carbonic anhydrase inhibitors, myocarditis, cyanosis, fatigue, headache, neuropathy, visual and hearing disturbances, dizziness, arthralgias, myopathies.

InteractionsThis section has been translated automatically.

See Table 1.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, hypersensitivity to sulfonamides, glucose-6-phosphate dehydrogenase deficiency, anemia, currently erythema exsudativum multiforme or toxic epidermal necrolysis, hemoglobin abnormalities, ileus, severe liver damage, leukopenia, acute hepatic porphyria, renal failure.

TablesThis section has been translated automatically.

Significant interactions of sulfonamides

Barbiturates

Blood formation disorders

Benzocaine

Sulfonamide effect ↓

Chloramphenicol

Blood formation disorder

Clofazemin

Sulfonamide effect ↓

Daunorubicin

Hyperuricemia

Didanosine

Sulfonamide effect ↓

Doxorubicin

Hyperuricemia

Contraceptives, oral

Contraception ↓

Methotrexate

MTX toxicity ↑

Phenytoin

Phenytoin levels ↑

Primaquine

Agranulocytosis

Probenecid

Sulfonamide toxicity ↑

Pyrimethamine

mutual effect ↑ (combination only recommended for toxoplasmosis)

Rifampicin

Sulfonamide effect ↓

Sulfonylureas

Hypoglycemia

Theophylline

Theophylline plasma levels ↑

Trimethoprim

Trimethoprim plasma mirror ↑

Authors

Last updated on: 07.10.2021